LicianPro

Doug Senko

Equity research analyst · UBS

Earnings calls

1

Nov 12, 2026 – Nov 12, 2026

Stocks asked about

1

Questions

1

Firm rating actions

0

on these stocks, from news

Coverage

Companies whose earnings calls Doug Senko asked questions on (from Lician's transcripts).

Questions on earnings calls

    • 49:13
      “So you guided to around $100 million of revenue growth year over year in fiscal 27. Around $40 million of this is attributed to AI as you guided to, I think, about 67%. Growth there. What drives the other $60 million? How much is mRNA? How much is liquid biopsy? How much is…”

Quotes are machine transcriptions of the official webcast (Whisper) and may contain errors; the timestamp opens the call at that moment.

UBS rating actions on these stocks

From news headlines Lician stores, each linked to its source. A headline names the firm; it may not name Doug Senko. We do not use licensed rating databases.

No rating action by UBS on these stocks in the headlines we store yet.